Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY.
Department of Biostatistics, University of Kentucky College of Public Health, Lexington, KY.
J Orthop Trauma. 2022 Aug 1;36(8):326-331. doi: 10.1097/BOT.0000000000002346. Epub 2022 Jan 6.
To determine whether the use of a multimodal analgesic protocol reduced short-term and long-term opioid use in patients hospitalized after orthopaedic trauma.
Retrospective pre-post intervention study.
Regional, academic, Level 1 trauma center in Central Kentucky.
PATIENTS/PARTICIPANTS: Patients were hospitalized after orthopaedic injury before (n = 393) and after (n = 378) the implementation of a multimodal analgesic protocol.
The intervention involved a multimodal analgesic protocol consisting of acetaminophen, ibuprofen/ketorolac, gabapentinoids, skeletal muscle relaxants, and standardized doses of opioids plus standardized pain management education before hospital discharge.
End points included discharge opioid prescription, days' supply and daily morphine milligram equivalent (MME), and long-term opioid use after hospitalization. Opioid use in the 90 days before and after hospitalization was assessed using state prescription drug monitoring program data.
Discharge opioid prescription rates were similar in the intervention and control cohorts [79.9% vs. 78.4%, odds ratio (OR) 1.30 (0.83-2.03), P = 0.256]. Patients in the intervention cohort received a shorter days' supply [5.7 ± 4.1 days vs. 8.1 ± 6.2 days, rate ratio 0.70 (0.65-0.76), P < 0.001] and lower average daily MME [34.8 ± 24.9 MME vs. 51.5 ± 44.0 MME, rate ratio 0.68 (0.62-0.75), P < 0.001]. The incidence of long-term opioid use was also significantly lower in the intervention cohort [7.7% vs. 12.0%, OR 0.53 (0.28-0.98), P = 0.044].
Implementation of a multimodal analgesic protocol was associated with reductions in both short-term and long-term opioid use, including long-term opioid therapy, after orthopaedic trauma.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
确定多模式镇痛方案是否减少了骨科创伤后住院患者短期和长期阿片类药物的使用。
回顾性前后干预研究。
肯塔基州中部地区的一个区域性、学术性、一级创伤中心。
患者/参与者:在多模式镇痛方案实施前(n=393)和后(n=378)接受骨科损伤住院的患者。
该干预措施包括多模式镇痛方案,其中包括对乙酰氨基酚、布洛芬/酮咯酸、加巴喷丁类药物、骨骼肌松弛剂以及在出院前给予标准化剂量的阿片类药物和标准化疼痛管理教育。
出院时的阿片类药物处方、供应天数和每日吗啡毫克当量(MME),以及住院后的长期阿片类药物使用。使用州处方药物监测计划数据评估住院前后 90 天的阿片类药物使用情况。
干预组和对照组的出院阿片类药物处方率相似[79.9%比 78.4%,比值比(OR)1.30(0.83-2.03),P=0.256]。干预组患者的供应天数更短[5.7±4.1 天比 8.1±6.2 天,比率 0.70(0.65-0.76),P<0.001],平均每日 MME 更低[34.8±24.9 MME 比 51.5±44.0 MME,比率 0.68(0.62-0.75),P<0.001]。干预组长期阿片类药物使用的发生率也显著降低[7.7%比 12.0%,OR 0.53(0.28-0.98),P=0.044]。
多模式镇痛方案的实施与骨科创伤后短期和长期阿片类药物使用的减少相关,包括长期阿片类药物治疗。
治疗性三级。有关证据水平的完整描述,请参见作者说明。